| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.
|
N Engl J Med
|
1992
|
3.11
|
|
2
|
Intracranial hypertension in head injury: management and results.
|
Intensive Care Med
|
1999
|
2.21
|
|
3
|
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.
|
J Clin Oncol
|
1999
|
2.19
|
|
4
|
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.
|
Ann Oncol
|
2006
|
1.47
|
|
5
|
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research.
|
Am J Clin Oncol
|
1989
|
1.38
|
|
6
|
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.
|
Ann Oncol
|
2005
|
1.22
|
|
7
|
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3).
|
Ann Oncol
|
1998
|
1.01
|
|
8
|
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial.
|
J Clin Oncol
|
1988
|
1.01
|
|
9
|
A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
|
Cancer Chemother Pharmacol
|
1990
|
0.92
|
|
10
|
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer.
|
Ann Oncol
|
2004
|
0.88
|
|
11
|
Complications and safety associated with ICP monitoring: a study of 542 patients.
|
Acta Neurochir Suppl
|
1998
|
0.88
|
|
12
|
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).
|
Ann Oncol
|
2006
|
0.84
|
|
13
|
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.
|
Br J Cancer
|
2004
|
0.82
|
|
14
|
Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
|
Semin Oncol
|
1988
|
0.81
|
|
15
|
Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancer.
|
Am J Clin Oncol
|
1989
|
0.81
|
|
16
|
Platinum and etoposide in chemotherapy refractory metastatic breast cancer. A phase II trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
|
Eur J Cancer Clin Oncol
|
1986
|
0.81
|
|
17
|
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group.
|
Ann Oncol
|
2002
|
0.80
|
|
18
|
Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma.
|
Br J Cancer
|
2003
|
0.80
|
|
19
|
Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: a randomized study comparing low versus high doses of cisplatin.
|
Tumori
|
1996
|
0.78
|
|
20
|
[Updating in occupational health for health care workers].
|
G Ital Med Lav Ergon
|
2008
|
0.78
|
|
21
|
A comparison of continuation versus late intensification followed by discontinuation of chemotherapy in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
|
Ann Oncol
|
1990
|
0.77
|
|
22
|
Medico-legal problems in cancer chemotherapy.
|
Acta Med Leg Soc (Liege)
|
1982
|
0.75
|
|
23
|
[Istituto Provincial per l'Assistenza all'Infanzia, as an expression of social pediatrics within the framework of social security].
|
Riv Clin Pediatr
|
1971
|
0.75
|
|
24
|
[Observations of growth of the premature infant, done in the Premature Infant Institute of Bologna during the 5 year periods 1929-1933 and 1959-1963].
|
Minerva Pediatr
|
1965
|
0.75
|
|
25
|
[Epidemiologic investigation of the occurrence of polycystic disease of the kidney at dialysis centers of Triveneto].
|
Minerva Urol Nefrol
|
1986
|
0.75
|
|
26
|
Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
|
Tumori
|
1989
|
0.75
|
|
27
|
, Serritelli G: [Serum and erythrocyte neuraminic acid in infants vaccinated at birth with S.D.V. (Salvioli's diffusing vaccine)].
|
Clin Pediatr (Bologna)
|
1969
|
0.75
|
|
28
|
[Mandatory or voluntary vaccinations? Juridical and medico-legal aspects].
|
Ann Ig
|
2004
|
0.75
|
|
29
|
5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer.
|
Tumori
|
1983
|
0.75
|
|
30
|
[Cancer screening: medico-legal aspects].
|
Ann Ig
|
2003
|
0.75
|
|
31
|
[Psycho-affective prophylaxis against the damages of institutionalization].
|
Minerva Pediatr
|
1971
|
0.75
|
|
32
|
[Congenital hip dysplasia in the newborn: diagnostics and prophylactic therapy].
|
Clin Pediatr (Bologna)
|
1968
|
0.75
|
|
33
|
[Fibrinolytic activity of the human brain after contusive injuries].
|
Minerva Med
|
1976
|
0.75
|
|
34
|
Humoral nonparathyroid hypercalcemia without evidence of bone involvement.
|
Tumori
|
1983
|
0.75
|
|
35
|
[Kidney transplant in patients with polycystic nephropathy].
|
Minerva Urol Nefrol
|
1986
|
0.75
|
|
36
|
[Role of the hospital pathologist with reference to matters of medicolegal relevance].
|
Pathologica
|
1984
|
0.75
|
|
37
|
Cisplatin and low-dose cytosine arabinoside in advanced cancer.
|
Tumori
|
1987
|
0.75
|
|
38
|
High-dose folinic acid and 5-fluorouracil in advanced colorectal cancer.
|
Cancer Invest
|
1988
|
0.75
|
|
39
|
Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.
|
Eur J Clin Pharmacol
|
1991
|
0.75
|
|
40
|
Risks of iatrogenic diseases from radiographic mass investigations for preventional purposes and discretional powers of the radiologist.
|
Acta Med Leg Soc (Liege)
|
1982
|
0.75
|
|
41
|
Vindesine and mitomycin C in chemotherapy: refractory advanced breast cancer.
|
Cancer
|
1986
|
0.75
|
|
42
|
[Letrozole (Femara), a new aromatase inhibitor for advanced breast cancer].
|
Vopr Onkol
|
1999
|
0.75
|
|
43
|
[Antipyretics, analgesics and antirheumatic agents in nipiologic age].
|
Minerva Nipiol
|
1969
|
0.75
|
|
44
|
Lung cancer after treatment of Hodgkin's disease--a case report.
|
Acta Oncol
|
1991
|
0.75
|